+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Safety Needles Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4845550
  • Report
  • Region: Global
  • 313 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton
  • Cardinal Health
  • Dickinson Company
  • Nipro Corporation
  • Novo Nordisk A/S
  • MORE
The safety needles market accounted for $1,609 million in 2018, and is expected to reach $3,009 million by 2026, registering a CAGR of 8.1% from 2019 to 2026.

Safety needle is a hollow, cylindrical needle bearing a puncturing point at the tip, which is attached to a syringe. It is used across medical settings in different applications such as drug delivery, vaccination, and blood specimen collection for examination and research purposes. These needles are referred to as safety needles due to the extra function they perform. For instance, these safety devices are equipped with sheaths used to cover the needle to prevent needlestick injuries, which can cause lethal infections. Moreover, these needles use different systems to provide safety against needlestick injuries such as active safety needles require manual activation, whereas passive safety needles do not require any activation and are automatic.

The factors that boost the growth of safety needles market include surge in prevalence of needlestick injuries and increase in cases of chronic diseases & infections. Moreover, other factors that contribute toward the growth of the market include favorable government initiatives related to the use of safety needles. However, factors such as high price of these needles and availability of alternative modes of drug delivery restrain the growth of the market. On the contrary, high growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

The global safety needle market is segmented based on product, end user, and region. On the basis of product, the market is bifurcated into active safety needles and passive safety needles. By end user, it is categorized into hospitals & ambulatory surgery centers, diabetic patients, family practice, psychiatry, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, Italy, Spain, France, Czech Republic, Republic of Moldova, Poland, Hungary, Romania, Russia, Slovakia, Ukraine, Greece, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Qatar, Lebanon, Jordan, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global safety needles market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments

By Product
o Active Safety Needles
o Passive Safety Needles

By End User
o Hospitals & Ambulatory Surgery Centers
o Diabetic Patients
o Family Practice
o Psychiatry
o Others
o Others

By Region

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Czech Republic
  • Republic of Moldova
  • Poland
  • Hungary
  • Romania
  • Russia
  • Slovakia
  • Ukraine
  • Greece
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • UAE
  • Qatar
  • Lebanon
  • Jordan
  • Rest of LAMEA
List of key players profiled in the report:
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health
  • Johnson & Johnson (Ethicon Inc.)
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Smiths Group Plc.
  • Terumo Corporatio
  • Vygon SA
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • DeRoyal Industries
  • Hindustan Syringes & Medical Devices Limited
  • Hi-Tech Syringes
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton
  • Cardinal Health
  • Dickinson Company
  • Nipro Corporation
  • Novo Nordisk A/S
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Porter'S Five Forces Analysis
3.3.1. Bargaining Power of Buyers
3.3.2. Bargaining Power of Suppliers
3.3.3. Thereat of New Entrants
3.3.4. Threat of Substitutes
3.3.5. Intensity of Competitive Rivalry
3.4. Top Player Positioning, 2018
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Rise In Prevalence of Needlestick Injuries
3.5.1.2. Favorable Government Initiatives Toward The Use of Safety Needles
3.5.1.3. Surge In Prevalence of Chronic Conditions And Infectious Diseases
3.5.2. Restraints
3.5.2.1. High Cost of Safety Needles
3.5.2.2. Availability of Alternative Modes of Delivery
3.5.3. Opportunity
3.5.3.1. High Growth Potential In Emerging Economies
3.5.4. Impact Analyses

Chapter 4: Safety Needles Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Active Safety Needles
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country (Value)
4.2.4. Market Analysis, By Country (Volume)
4.3. Passive Safety Needles
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country (Value)
4.3.4. Market Analysis, By Country (Volume)

Chapter 5: Safety Needles Market, By End User
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Hospitals & Ambulatory Surgery Centers
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country (Value)
5.2.3. Market Analysis, By Country (Volume)
5.2.4. Diabetic Patients
5.2.5. Market Size And Forecast
5.2.6. Market Analysis, By Country (Value)
5.2.7. Market Analysis, By Country (Volume)
5.3. Psychiatry
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country (Value)
5.3.3. Market Analysis, By Country (Volume)
5.4. Family Practice
5.4.1. Market Size And Forecast
5.4.2. Market Analysis, By Country (Value)
5.4.3. Market Analysis, By Country (Volume)
5.5. Others
5.5.1. Market Size And Forecast
5.5.2. Market Analysis, By Country (Value)
5.5.3. Market Analysis, By Country (Volume)

Chapter 6: Safety Needles Market, By Region
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends, Growth Factors, And Opportunities
6.2.2. Market Analysis By Country
6.2.2.1. U.S.
6.2.2.1.1. U.S. Market Size And Forecast, By Product
6.2.2.1.2. U.S. Market Size And Forecast, By End User
6.2.2.2. Canada
6.2.2.2.1. Canada Market Size And Forecast, By Product
6.2.2.2.2. Canada Market Size And Forecast, By End User
6.2.2.3. Mexico
6.2.2.3.1. Mexico Market Size And Forecast, By Product
6.2.2.3.2. Mexico Market Size And Forecast, By End User
6.2.3. North America Safety Needles Market, By Product
6.2.4. North America Safety Needles Market, By End User
6.3. Europe
6.3.1. Key Market Trends, Growth Factors, And Opportunities
6.3.2. Market Analysis By Country
6.3.2.1. Germany
6.3.2.1.1. Germany Market Size And Forecast, By Product
6.3.2.1.2. Germany Market Size And Forecast, By End User
6.3.2.2. France
6.3.2.2.1. France Market Size And Forecast, By Product
6.3.2.2.2. France Market Size And Forecast, By End User
6.3.2.3. UK
6.3.2.3.1. UK Market Size And Forecast, By Product
6.3.2.3.2. UK Market Size And Forecast, By End User
6.3.2.4. Italy
6.3.2.4.1. Italy Market Size And Forecast, By Product
6.3.2.4.2. Italy Market Size And Forecast, By End User
6.3.2.5. Spain
6.3.2.5.1. Spain Market Size And Forecast, By Product
6.3.2.5.2. Spain Market Size And Forecast, By End User
6.3.2.6. Poland
6.3.2.6.1. Poland Market Size And Forecast, By Product
6.3.2.6.2. Poland Market Size And Forecast, By End User
6.3.2.7. Czech Republic
6.3.2.7.1. Czech Republic Market Size And Forecast, By Product
6.3.2.7.2. Czech Republic Market Size And Forecast, By End User
6.3.2.8. Republic of Moldova
6.3.2.8.1. Republic of Moldova Market Size And Forecast, By Product
6.3.2.8.2. Republic of Moldova Market Size And Forecast, By End User
6.3.2.9. Hungary
6.3.2.9.1. Hungary Market Size And Forecast, By Product
6.3.2.9.2. Hungary Market Size And Forecast, By End User
6.3.2.10. Romania
6.3.2.10.1. Romania Market Size And Forecast, By Product
6.3.2.10.2. Romania Market Size And Forecast, By End User
6.3.2.11. Russia
6.3.2.11.1. Russia Market Size And Forecast, By Product
6.3.2.11.2. Russia Market Size And Forecast, By End User
6.3.2.12. Slovakia
6.3.2.12.1. Slovakia Market Size And Forecast, By Product
6.3.2.12.2. Slovakia Market Size And Forecast, By End User
6.3.2.13. UKraine
6.3.2.13.1. UKraine Market Size And Forecast, By Product
6.3.2.13.2. UKraine Market Size And Forecast, By End User
6.3.2.14. Greece
6.3.2.14.1. Greece Market Size And Forecast, By Product
6.3.2.14.2. Greece Market Size And Forecast, By End User
6.3.2.15. Rest of Europe
6.3.2.15.1. Rest of Europe Market Size And Forecast, By Product
6.3.2.15.2. Rest of Europe Market Size And Forecast, By End User
6.3.3. Europe Safety Needles Market, By Product
6.3.4. Europe Safety Needles Market, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends, Growth Factors, And Opportunities
6.4.2. Market Analysis By Country
6.4.2.1. Japan
6.4.2.1.1. Japan Market Size And Forecast, By Product
6.4.2.1.2. Japan Market Size And Forecast, By End User
6.4.2.2. China
6.4.2.2.1. China Market Size And Forecast, By Product
6.4.2.2.2. China Market Size And Forecast, By End User
6.4.2.3. Australia
6.4.2.3.1. Australia Market Size And Forecast, By Product
6.4.2.3.2. Australia Market Size And Forecast, By End User
6.4.2.4. India
6.4.2.4.1. India Market Size And Forecast, By Product
6.4.2.4.2. India Market Size And Forecast, By End User
6.4.2.5. South Korea
6.4.2.5.1. South Korea Market Size And Forecast, By Product
6.4.2.5.2. South Korea Market Size And Forecast, By End User
6.4.2.6. Taiwan
6.4.2.6.1. Taiwan Market Size And Forecast, By Product
6.4.2.6.2. Taiwan Market Size And Forecast, By End User
6.4.2.7. Rest of Asia-Pacific
6.4.2.7.1. Rest of Asia-Pacific Market Size And Forecast, By Product
6.4.2.7.2. Rest of Asia-Pacific Market Size And Forecast, By End User
6.4.3. Asia-Pacific Safety Needles Market, By Product
6.4.4. Asia-Pacific Safety Needles Market, By End User
6.5. LAMEA
6.5.1. Key Market Trends, Growth Factors, And Opportunities
6.5.2. Market Analysis By Country
6.5.2.1. Brazil
6.5.2.1.1. Brazil Market Size And Forecast, By Product
6.5.2.1.2. Brazil Market Size And Forecast, By End User
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia Market Size And Forecast, By Product
6.5.2.2.2. Saudi Arabia Market Size And Forecast, By End User
6.5.2.3. South Africa
6.5.2.3.1. South Africa Market Size And Forecast, By Product
6.5.2.3.2. South Africa Market Size And Forecast, By End User
6.5.2.4. UAE
6.5.2.4.1. UAE Market Size And Forecast, By Product
6.5.2.4.2. UAE Market Size And Forecast, By End User
6.5.2.5. Qatar
6.5.2.5.1. Qatar Market Size And Forecast, By Product
6.5.2.5.2. Qatar Market Size And Forecast, By End User
6.5.2.6. Lebanon
6.5.2.6.1. Lebanon Market Size And Forecast, By Product
6.5.2.6.2. Lebanon Market Size And Forecast, By End User
6.5.2.7. Jordan
6.5.2.7.1. Jordan Market Size And Forecast, By Product
6.5.2.7.2. Jordan Market Size And Forecast, By End User
6.5.2.8. Rest of LAMEA
6.5.2.8.1. Rest of LAMEA Market Size And Forecast, By Product
6.5.2.8.2. Rest of LAMEA Market Size And Forecast, By End User
6.5.3. LAMEA Safety Needles Market, By Product
6.5.4. LAMEA Safety Needles Market, By End User

Chapter 7: Company Profiles
7.1. B. Braun Melsungen Ag
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Becton, Dickinson And Company
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Cardinal Health
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Johnson & Johnson (Ethicon Inc.)
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Nipro Corporation
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.5.6. Key Strategic Moves And Developments
7.6. Novo Nordisk A/S
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Retractable Technologies, Inc.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Smiths Group Plc.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Terumo Corporation
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Vygon Sa
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Product Portfolio

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton
  • Cardinal Health
  • Dickinson Company
  • Nipro Corporation
  • Novo Nordisk A/S
  • MORE
According to the report titled, 'Safety needles Market by Product, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2026,' The safety needles market accounted for $1,609 million in 2018, and is expected to reach $3,009 million by 2026, registering a CAGR of 8.1% from 2019 to 2026.

Safety needles are hollow, cylindrical metal rods with a puncture point at the pointed tip. These needles are utilized to inject solutions through subcutaneous, intravenous, and intramuscular modes for rapid uptake of substances such as insulin, drugs, and others. Safety needles are equipped with a sheath that is placed over the needle. In some devices, the needle retracts into the barrel of the syringe post injection. These devices are designed in this manner to prevent needlestick injuries in healthcare workers. Moreover, safety needles are used to extract body fluids for diagnosis.

The global safety needles market witness’s significant growth, owing to factors such as increase in cases of chronic diseases & infections and surge in prevalence of needlestick injuries. Favorable government initiatives related to the use of safety needles boosts the growth of market. However, high price of safety needles and availability of alternative modes of drug delivery hamper the growth of the market. Conversely, high growth potential in emerging economies is expected to create lucrative opportunities for market expansion during the forecast period.

The global safety needles market is segmented based on product, end user, and region, both in terms of both value and volume. Depending on product, the market is bifurcated into active safety needles and passive safety needles. By end user, it is fragmented into hospitals and surgery centers, diabetic patients, family practice, psychiatry, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, Italy, Spain, France, Czech Republic, Republic of Moldova, Poland, Hungary, Romania, Russia, Slovakia, Ukraine, Greece, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Qatar, Lebanon, Jordan, and rest of LAMEA).

Based on product, the active safety needles segment acquired the major share, as these devices experience higher adoption as compared to passive safety needles. Moreover, comparatively lower price of active safety needles boosts the growth of this segment. However, the passive safety needles is anticipated to growth at the highest rate during the forecast period, owing to ease of use these devices offer, as the safety feature is automatic. In addition, passive needles are equipped with non-removable integral safety system and require less disposable space, which fuel their adoption across the globe. These features serve as an advantage to the pharmaceutical manufacturers by eliminating extra assembly steps.

Based on end user, the hospitals & ambulatory surgery centers segment dominated the safety needles market, as these devices are majorly used in drug administration and blood sample collection, which are majorly performed by highly trained medical staff in hospitals and surgery centers. However, the psychiatry segment is expected to grow at a significant rate during the forecast period, owing to rise in awareness related to need of safety needles in psychiatry. This is attributed to the elevated risk of needlestick injuries to healthcare workers in psychiatry

In 2018, North America accounted for the major share of safety needles market, and is expected to continue this trend during the forecast period, owing to rise in cases of needlestick injuries in the region. Moreover, other factors such as easy availability of safety needles, presence of key players, and surge in adoption of safety needles boost the market growth. However, Asia-Pacific is expected to exhibit fastest growth rate, owing to surge in awareness related to harmful outcomes of needlestick injuries. Furthermore, upsurge in prevalence of fatal infections that can be transmitted through needlestick injuries and rise in healthcare expenditure in the region are the key factors that significantly contribute toward the growth of the market. The constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, Malaysia, and others, thus providing lucrative opportunities to the safety needles providers for expansion for their businesses.

Key Findings of the Safety needles Market:

Active safety needles occupied 70.90% share of the global safety needles market in 2018
The psychiatry segment is anticipated to grow with the highest CAGR throughout the forecast period
The hospitals & ambulatory surgery centers segment accounted for 31.78% share of the market in 2018
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA'
Note: Product cover images may vary from those shown
5 of 5
  • B. Braun Melsungen AG
  • Becton
  • Dickinson Company
  • Cardinal Health
  • Johnson & Johnson (Ethicon Inc.)
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies Inc.
  • Smiths Group Plc.
  • Terumo Corporation
  • Vygon SA.
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll